ENTITY
DOD Biotech

DOD Biotech (DOD TB)

17
Analysis
Health Care • Thailand
DOD Biotech Public Co., Ltd. is a leading contract manufacturer (OEM/ODM) of dietary supplements and health drinks in Thailand. The company offers a complete range of services for creating and producing health supplement brands, including capsules, gels, jellies, powders, softgels, tablets, probiotics, gummies, and concentrated liquid products. Headquartered in Samut Sakhon, Thailand, the company was founded in 2017.
more
bullish•DOD Biotech
•02 Jun 2021 09:42•Exchange-sponsored

DOD: Failed Investment in Cosmetics Requires New Strategy

We maintained a HOLD recommendation on DOD and an unchanged target price of Bt13.30, implying an upside of 2% from the current price.

Share
bullish•DOD Biotech
•10 Mar 2021 15:46•Exchange-sponsored

DOD: Recent Bullish Rally Overestimates Hemp Hype

We change our recommendation to a HOLD from BUY after DOD showed a strong price rally. But we increase our target price to Bt13.30 from Bt10.70,...

Share
bullish•DOD Biotech
•01 Dec 2020 09:38•Exchange-sponsored

DOD: More to Come in Beauty Products and Network Marketing

We keep our BUY recommendation on DOD based on our target price of Bt10.70, implying an upside of 18%. We derive our target price from the 2021E PB...

Share
bullish•DOD Biotech
•01 Sep 2020 11:51•Exchange-sponsored

DOD: Strong Performance Deserves a Re-Rating

We upgrade our recommendation on DOD to BUY from HOLD based on raising our target price to Bt10.70 from Bt7.55, implying an upside of 26%.

Share
bearish•DOD Biotech
•02 Jul 2020 09:09•Exchange-sponsored

DOD: Pronounced Growth Prospects, but Stock Is Fully Valued

We initiate coverage on DOD with a HOLD recommendation based on a target price of Bt7.55, implying a downside of 6% from the current price. We...

Share
x